Literature DB >> 8964402

Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets.

R Cuenca1, T G Blanchard, S J Czinn, J G Nedrud, T P Monath, C K Lee, R W Redline.   

Abstract

BACKGROUND & AIMS: Helicobacter infection of the gastric antrum is responsible for a number of gastric disorders. Antibiotic therapy is lengthy and is not always effective. It has been shown previously that oral immunization against Helicobacter felis in mice can prevent colonization after challenge. The aim of this study was to investigate the efficacy of therapeutic immunization in eradicating an established Helicobacter infection and in reducing gastritis.
METHODS: Domestic ferrets, confirmed to be infected with Helicobacter mustelae by gastric endoscopy, were orally immunized with varying doses of purified Helicobacter pylori urease in combination with the mucosal adjuvant cholera toxin. Ferrets were assessed 1 week and 6 weeks after treatment for infection and pathology.
RESULTS: Therapeutic immunization eradicated Helicobacter colonization in 30% of all immunized ferrets, although there was no difference in efficacy between the varying doses of antigen tested. The difference was statistically significant when compared with animals administered cholera toxin alone or buffer (P = 0.04). The intensity of inflammation was also significantly reduced in immunized animals (P = 0.0003).
CONCLUSIONS: Oral immunization with purified H. pylori urease and cholera toxin can eradicate H. mustelae in a natural host pathogen model. Oral immunization of chronically infected animals markedly reduced gastric inflammation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964402     DOI: 10.1053/gast.1996.v110.pm8964402

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa.

Authors:  H A Haeberle; M Kubin; K B Bamford; R Garofalo; D Y Graham; F El-Zaatari; R Karttunen; S E Crowe; V E Reyes; P B Ernst
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 3.  Immunopathology of Helicobacter pylori infection and disease.

Authors:  S J Czinn; J G Nedrud
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice.

Authors:  K A Eaton; M E Mefford
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 5.  Identification of Helicobacter pylori and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease.

Authors:  Thomas G Blanchard; Steven J Czinn
Journal:  Pediatr Res       Date:  2016-10-04       Impact factor: 3.756

6.  Urease-based mucosal immunization against Helicobacter heilmannii infection induces corpus atrophy in mice.

Authors:  C Dieterich; H Bouzourène; A L Blum; I E Corthésy-Theulaz
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  H. pylori vaccines: why we still don't have any.

Authors:  Songhua Zhang; Leonard Moise; Steven F Moss
Journal:  Hum Vaccin       Date:  2011-11-01

Review 8.  Vaccinating against Helicobacter pylori in the developing world.

Authors:  Shamila Zawahir; Steven J Czinn; John G Nedrud; Thomas G Blanchard
Journal:  Gut Microbes       Date:  2013-11-06

9.  Comparative genomics and proteomics of Helicobacter mustelae, an ulcerogenic and carcinogenic gastric pathogen.

Authors:  Paul W O'Toole; William J Snelling; Carlos Canchaya; Brian M Forde; Kim R Hardie; Christine Josenhans; Robert Lj Graham; Geoff McMullan; Julian Parkhill; Eugenio Belda; Stephen D Bentley
Journal:  BMC Genomics       Date:  2010-03-10       Impact factor: 3.969

10.  Mucosal immunization with helicobacter, CpG DNA, and cholera toxin is protective.

Authors:  Weiwen Jiang; Henry J Baker; Bruce F Smith
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.